We next asked whether UL138 could inhibit the IFN-β promoter in cell types in which HCMV initiates a productive, lytic infection (normal human dermal fibroblasts [NHDFs]) or establishes latency (THP-1 monocytes). The gene discussed is IFNB1; the disease is infection.